
JAZZ
Healthcare · Biotechnology · $15.50B market cap
$241.55+1.18 (+0.5%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +3.1% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 2, 2026 | After the close | -5.18 | -4.83 | +6.8% |
| Aug 3, 2026 | After the close | 5.06 | 4.89 | -3.4% |
| May 5, 2026 | After the close | 4.66 | 6.34 | +36.1% |
| Feb 25, 2026 | Time not confirmed | 6.51 | 6.64 | +2.1% |
| Nov 5, 2025 | After the close | 4.80 | 6.99 | +45.6% |
| Aug 5, 2025 | After the close | -6.25 | -8.25 | -32.0% |
| May 6, 2025 | After the close | 4.66 | 1.68 | -63.9% |
| Feb 25, 2025 | After the close | 5.81 | 6.60 | +13.6% |
| Nov 6, 2024 | After the close | 5.50 | 6.61 | +20.2% |
| Jul 31, 2024 | After the close | 4.78 | 5.30 | +10.9% |
| May 1, 2024 | After the close | 4.18 | 2.68 | -35.9% |
| Feb 28, 2024 | After the close | 5.18 | 5.02 | -3.1% |
| Nov 8, 2023 | After the close | 4.93 | 4.84 |
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the…
| -1.8% |
| Aug 9, 2023 | After the close | 4.43 | 4.51 | +1.8% |
| May 10, 2023 | After the close | 4.22 | 3.95 | -6.4% |
| Mar 1, 2023 | After the close | 0.32 | -0.07 | -121.9% |
| Nov 9, 2022 | After the close | 4.67 | 5.17 | +10.7% |
| Aug 3, 2022 | After the close | 4.19 | 4.30 | +2.6% |
| May 4, 2022 | After the close | 3.89 | 3.73 | -4.1% |
| Mar 1, 2022 | After the close | 3.64 | 4.21 | +15.7% |
| Nov 9, 2021 | After the close | 3.31 | 4.20 | +26.9% |
| Aug 3, 2021 | After the close | 3.45 | 3.90 | +13.0% |
| May 4, 2021 | After the close | 3.73 | 3.92 | +5.1% |
| Feb 23, 2021 | After the close | 4.20 | 4.00 | -4.8% |
| Nov 2, 2020 | After the close | 4.08 | 4.31 | +5.6% |
| Aug 4, 2020 | After the close | 3.11 | 3.71 | +19.3% |
| May 5, 2020 | After the close | 0.67 | 0.45 | -32.8% |
| Feb 25, 2020 | After the close | 4.12 | 4.42 | +7.3% |
| Nov 5, 2019 | After the close | 3.59 | 4.10 | +14.2% |
| Aug 6, 2019 | After the close | 3.57 | 4.05 | +13.4% |
| May 7, 2019 | After the close | 3.16 | 3.67 | +16.1% |
| Feb 26, 2019 | After the close | 3.02 | 3.64 | +20.5% |
| Nov 6, 2018 | After the close | 3.32 | 3.58 | +7.8% |
| Aug 7, 2018 | After the close | 3.21 | 3.49 | +8.7% |
| May 8, 2018 | After the close | 2.78 | 2.98 | +7.2% |
| Feb 27, 2018 | After the close | 2.98 | 2.95 | -1.0% |